~~<i id='C2648A8F60'><strike id='C2648A8F60'><tt id='C2648A8F60'><pre id='C2648A8F60'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

leisure time

comprehensive

author：knowledge 2025-09-28 00:51:07 - browse：13989

It’s that time of the year again when I recognize the Best Biopharma CEO of the year.

This year’s selection is so deservingly obvious that I won’t fabricate suspense by starting with an honor roll of runners-up. More on those high-achieving folks later. Let’s get right to the main course: David Ricks of Eli Lillyis the runaway, rock star, who-else-could-it-be Best Biopharma CEO of 2023.

What an incredible year it’s been for Ricks and the Lilly executive team who helped him achieve so much. My colleague Matt Herper wrote earlier this year about the “dynamic duo” of Ricks and Chief Scientific Officer Dan Skovronsky.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： CDC Director Mandy Cohen on transparency, trust, and health

entertainment

knowledge

leisure time

explore

entertainment

hotspot

NewYork-PresbyterianHospitalreceived$631millionfromtheCovid-19ProviderReliefFund.CindyOrd/GettyImage

WSS

What it's like to live with paralysis for one psychologist

Truvian presents data for its desktop blood

The battle over 'scope creep' and who gets to be called 'doctor'

What to watch for from Zogenix and Amicus clinical trials

CDC Director Mandy Cohen on transparency, trust, and health

Biogen says it will cut costs by $700 million, slash 1,000 jobs

leisure time

comprehensive

entertainment

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Why patients can’t get everything they want on drug pricing

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Ionis drug prevents swelling attacks due to hereditary angioedema

The high cost of giving birth even with insurance

ASCO: Palliative care found as helpful given virtually as in person

State Dept. review finds Biden bears some blame for Afghanistan failures

Innovation in antibiotics is ailing. 'Brain drain' may kill it

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Dems pitch expanding Medicare power to negotiate drug prices

knowledge

Democrats decry new health bill for going easy on private equity

The Pandemic Treaty must support building strong health systems

Ultragenyx gene therapy for rare liver ailment succeeds in late

Change Healthcare can notify patients about the breach, HHS says

ASCO Daily Recap: Safety data from Novartis, survival from Pfizer

Ultragenyx gene therapy for rare liver ailment succeeds in late

leisure time

explore

entertainment

hotspot